Soleno Therapeutics (SLNO) News Today $72.94 -2.11 (-2.80%) As of 01:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Vestal Point Capital LP Buys 340,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Vestal Point Capital LP lifted its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 47.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,060,000 shares of the company'sMay 21 at 8:14 AM | marketbeat.comDeutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Deutsche Bank AG grew its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 44.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,455 shares of the company's stock after buying an additMay 21 at 3:52 AM | marketbeat.comSoleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Willi SyndromeMay 20 at 4:16 PM | globenewswire.comTang Capital Management LLC Buys New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Tang Capital Management LLC purchased a new stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,000 shares of the company's stock, valuedMay 20 at 6:24 AM | marketbeat.comTema Etfs LLC Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Tema Etfs LLC acquired a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 13,178 shares of the company's stock, valued at approximately $592,000. A number of other instMay 20 at 6:23 AM | marketbeat.comNorthern Trust Corp Buys 34,309 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Northern Trust Corp raised its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 17.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 226,889 shares of the company's stock after acquiring anMay 20 at 3:31 AM | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Position Boosted by Ensign Peak Advisors IncEnsign Peak Advisors Inc increased its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 95.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,201 shares of the company's stock afMay 19 at 4:14 AM | marketbeat.comPolar Asset Management Partners Inc. Raises Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Polar Asset Management Partners Inc. boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 296.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,400 shares of the compMay 18 at 6:07 AM | marketbeat.comBNP Paribas Financial Markets Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)BNP Paribas Financial Markets purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 71,320 shares of the company's stock, valued at approximately $3,2May 18 at 3:31 AM | marketbeat.comJanus Henderson Group PLC Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Janus Henderson Group PLC raised its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 27.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,188,265 shares of the company's stock after purchasing aMay 14, 2025 | marketbeat.comSoleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025May 13, 2025 | finance.yahoo.comFred Alger Management LLC Boosts Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Fred Alger Management LLC lifted its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 140.9% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,805 shares of the company's stock after buying an addiMay 13, 2025 | marketbeat.comEquities Analysts Issue Forecasts for SLNO FY2025 EarningsMay 13, 2025 | americanbankingnews.comSLNO FY2025 EPS Estimate Decreased by Cantor FitzgeraldSoleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of Soleno Therapeutics in a report issued on Thursday, May 8th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earninMay 13, 2025 | marketbeat.comCrestline Management LP Purchases Shares of 12,943 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Crestline Management LP acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,943 shares ofMay 12, 2025 | marketbeat.comIs Soleno Therapeutics (SLNO) the Best Performing Healthcare Stock to Buy Now?May 11, 2025 | insidermonkey.comFarallon Capital Management LLC Buys New Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Farallon Capital Management LLC acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 90,000 shares of the company's stock, valued at apMay 11, 2025 | marketbeat.comRobert W. Baird Increases Soleno Therapeutics (NASDAQ:SLNO) Price Target to $105.00Robert W. Baird increased their target price on shares of Soleno Therapeutics from $102.00 to $105.00 and gave the stock an "outperform" rating in a research note on Thursday.May 10, 2025 | marketbeat.comSoleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025May 9, 2025 | uk.finance.yahoo.comSoleno Therapeutics Inc (SLNO) Q1 2025 Earnings Call Highlights: Navigating Early Success and ...May 8, 2025 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High - What's Next?Soleno Therapeutics (NASDAQ:SLNO) Reaches New 12-Month High - Should You Buy?May 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by Tower Research Capital LLC TRCTower Research Capital LLC TRC grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 811.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,304 shares of the company's stock after acquiring an additional 3,832 shares during thMay 8, 2025 | marketbeat.comSoleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comSoleno Therapeutics shares rise on VYKAT XR launch updateMay 7, 2025 | in.investing.comSoleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial ResultsMay 7, 2025 | globenewswire.comAlyeska Investment Group L.P. Sells 552,024 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Alyeska Investment Group L.P. lowered its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 56.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 424,081 shares of the company's stock aftMay 7, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Comerica BankComerica Bank grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 242.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 121,213 shares of the compMay 7, 2025 | marketbeat.comInvesco Ltd. Lowers Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Invesco Ltd. trimmed its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 96.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,012 shares of the company's stock after selling 322,157 shaMay 6, 2025 | marketbeat.comMariner LLC Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Mariner LLC acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,303 shares of the companyMay 5, 2025 | marketbeat.comWells Fargo & Company MN Acquires 3,610 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Wells Fargo & Company MN increased its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 40.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,547 shares of the company's stock after acquiring an addMay 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Ally Bridge Group NY LLC purchased a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 87,629 shares of the company's stoMay 4, 2025 | marketbeat.comSoleno Therapeutics (SLNO) Projected to Post Earnings on WednesdaySoleno Therapeutics (NASDAQ:SLNO) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-soleno-therapeutics-inc-stock/)May 2, 2025 | marketbeat.comAquatic Capital Management LLC Invests $1.31 Million in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Aquatic Capital Management LLC purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 29,208 shares of the company's stock, valued at approximately $1,313,000. AquaticMay 2, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Emerald Mutual Fund Advisers TrustEmerald Mutual Fund Advisers Trust raised its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 58.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 368,574 shares of the company's stock after purchasing an addMay 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Grows Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Price T Rowe Associates Inc. MD increased its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 24.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,630,718 shares of the companMay 1, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Position Lifted by Nantahala Capital Management LLCNantahala Capital Management LLC boosted its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,928,966 shares of the company's stoApril 30, 2025 | marketbeat.comArtia Global Partners LP Increases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Artia Global Partners LP raised its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 80.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 494,424 shares of the company's stock after purchasApril 29, 2025 | marketbeat.com6,292 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Acquired by XTX Topco LtdXTX Topco Ltd acquired a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 6,292 shares of the company's stock, valued at approximately $283,000. A numApril 28, 2025 | marketbeat.comBarclays PLC Has $5.69 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Barclays PLC grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 141.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 126,675 shares of the company's stock after purchasing an additional 74,130 shares duriApril 28, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by AnalystsSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) has received a consensus recommendation of "Buy" from the ten brokerages that are presently covering the firm, Marketbeat reports. Eight analysts have rated the stock with a buy rating and two have issued a strong buy rating on the companyApril 27, 2025 | marketbeat.comJump Financial LLC Buys Shares of 11,819 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Jump Financial LLC purchased a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,819 shares of the company's stock, valueApril 26, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. decreased its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 16.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,775,976 shares of the company's stock after selling 546,170April 25, 2025 | marketbeat.comSoleno Therapeutics price target raised to $145 from $93 at Piper SandlerApril 25, 2025 | markets.businessinsider.comPiper Sandler Sticks to Its Buy Rating for Soleno Therapeutics (SLNO)April 25, 2025 | markets.businessinsider.comAvoro Capital Advisors LLC Has $113.50 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Avoro Capital Advisors LLC increased its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 15.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,525,000 sharesApril 23, 2025 | marketbeat.comSoleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ETApril 23, 2025 | globenewswire.com124,095 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Bought by Rock Springs Capital Management LPRock Springs Capital Management LP acquired a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 124,095 shares of the company's stock,April 23, 2025 | marketbeat.comMarshall Wace LLP Grows Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Marshall Wace LLP increased its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 61.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 399,849 shares of the company's stock after buying an additional 152,010April 23, 2025 | marketbeat.comNan Fung Group Holdings Ltd Boosts Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Nan Fung Group Holdings Ltd lifted its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 24.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,650 shares of the company's stock after purchasApril 21, 2025 | marketbeat.comWalleye Capital LLC Invests $3.46 Million in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Walleye Capital LLC purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 76,934 shares of the company's stock, valued at approximately $3,458,00April 20, 2025 | marketbeat.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼1.180.65▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼95▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Solventum News Smith & Nephew News Penumbra News Stevanato Group News Glaukos News Inari Medical News iRhythm Technologies News Inspire Medical Systems News Bausch + Lomb News TransMedics Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLNO Stock Free SLNO Stock Alerts